Heterogeneity constitutes a critical barrier to treating cancer. This Review discusses the biological and physical sources of heterogeneity across length scales, encompassing tumour-cell-intrinsic, tissue-microenvironment and organism-level sources, and how engineering strategies can improve our understanding of these phenomena.
- Garrett F. Beeghly
- Adrian A. Shimpi
- Claudia Fischbach
